Apellis Pharmaceuticals Statistics
Total Valuation
APLS has a market cap or net worth of $5.25 billion. The enterprise value is $5.32 billion.
| Market Cap | 5.25B |
| Enterprise Value | 5.32B |
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
APLS has 128.02 million shares outstanding. The number of shares has increased by 5.48% in one year.
| Current Share Class | 128.02M |
| Shares Outstanding | 128.02M |
| Shares Change (YoY) | +5.48% |
| Shares Change (QoQ) | +3.76% |
| Owned by Insiders (%) | 3.37% |
| Owned by Institutions (%) | 73.73% |
| Float | 83.22M |
Valuation Ratios
The trailing PE ratio is 39.98.
| PE Ratio | 39.98 |
| Forward PE | n/a |
| PS Ratio | 4.75 |
| Forward PS | 5.79 |
| PB Ratio | 12.65 |
| P/TBV Ratio | 12.66 |
| P/FCF Ratio | 140.20 |
| P/OCF Ratio | 139.07 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.94, with an EV/FCF ratio of 142.06.
| EV / Earnings | 39.94 |
| EV / Sales | 4.82 |
| EV / EBITDA | 31.94 |
| EV / EBIT | 32.21 |
| EV / FCF | 142.06 |
Financial Position
The company has a current ratio of 3.63, with a Debt / Equity ratio of 1.15.
| Current Ratio | 3.63 |
| Quick Ratio | 3.00 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | 2.68 |
| Debt / FCF | 12.70 |
| Interest Coverage | 3.79 |
Financial Efficiency
Return on equity (ROE) is 46.02% and return on invested capital (ROIC) is 37.84%.
| Return on Equity (ROE) | 46.02% |
| Return on Assets (ROA) | 10.93% |
| Return on Invested Capital (ROIC) | 37.84% |
| Return on Capital Employed (ROCE) | 20.68% |
| Weighted Average Cost of Capital (WACC) | 3.40% |
| Revenue Per Employee | $1.50M |
| Profits Per Employee | $180,337 |
| Employee Count | 739 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 3.47 |
Taxes
In the past 12 months, APLS has paid $1.88 million in taxes.
| Income Tax | 1.88M |
| Effective Tax Rate | 1.39% |
Stock Price Statistics
The stock price has increased by +137.44% in the last 52 weeks. The beta is -0.25, so APLS's price volatility has been lower than the market average.
| Beta (5Y) | -0.25 |
| 52-Week Price Change | +137.44% |
| 50-Day Moving Average | 32.78 |
| 200-Day Moving Average | 25.97 |
| Relative Strength Index (RSI) | 84.49 |
| Average Volume (20 Days) | 7,226,660 |
Short Selling Information
The latest short interest is 10.75 million, so 8.40% of the outstanding shares have been sold short.
| Short Interest | 10.75M |
| Short Previous Month | 14.24M |
| Short % of Shares Out | 8.40% |
| Short % of Float | 12.92% |
| Short Ratio (days to cover) | 1.15 |
Income Statement
In the last 12 months, APLS had revenue of $1.11 billion and earned $133.27 million in profits. Earnings per share was $1.03.
| Revenue | 1.11B |
| Gross Profit | 710.47M |
| Operating Income | 165.22M |
| Pretax Income | 135.15M |
| Net Income | 133.27M |
| EBITDA | 166.63M |
| EBIT | 165.22M |
| Earnings Per Share (EPS) | $1.03 |
Balance Sheet
The company has $406.20 million in cash and $475.76 million in debt, with a net cash position of -$69.56 million or -$0.54 per share.
| Cash & Cash Equivalents | 406.20M |
| Total Debt | 475.76M |
| Net Cash | -69.56M |
| Net Cash Per Share | -$0.54 |
| Equity (Book Value) | 414.92M |
| Book Value Per Share | 3.24 |
| Working Capital | 744.57M |
Cash Flow
In the last 12 months, operating cash flow was $37.77 million and capital expenditures -$305,000, giving a free cash flow of $37.47 million.
| Operating Cash Flow | 37.77M |
| Capital Expenditures | -305,000 |
| Depreciation & Amortization | 1.40M |
| Net Borrowing | n/a |
| Free Cash Flow | 37.47M |
| FCF Per Share | $0.29 |
Margins
Gross margin is 64.28%, with operating and profit margins of 14.95% and 12.06%.
| Gross Margin | 64.28% |
| Operating Margin | 14.95% |
| Pretax Margin | 12.23% |
| Profit Margin | 12.06% |
| EBITDA Margin | 15.08% |
| EBIT Margin | 14.95% |
| FCF Margin | 3.39% |
Dividends & Yields
APLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.48% |
| Shareholder Yield | -5.48% |
| Earnings Yield | 2.54% |
| FCF Yield | 0.71% |
Analyst Forecast
The average price target for APLS is $35.53, which is -13.40% lower than the current price. The consensus rating is "Hold".
| Price Target | $35.53 |
| Price Target Difference | -13.40% |
| Analyst Consensus | Hold |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 8.63% |
| EPS Growth Forecast (5Y) | 49.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
APLS has an Altman Z-Score of 0.95 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.95 |
| Piotroski F-Score | 6 |